SlideShare ist ein Scribd-Unternehmen logo
1 von 76
ENDOMYOCARDIAL FIBROSIS
(Davies' disease)
DR VISHWANATH HESARUR
SENIOR RESIDENT
DEPT OF CARDIOLOGY
JNMC, BELGAUM.
INTRODUCTION
 Endomyocardial fibrosis (EMF) is a disease that is
characterized by fibrosis of the apical endocardium of the
right ventricle (RV), left ventricle (LV), or both.
 The clinical manifestations are largely related to the
consequences of restrictive ventricular filling, including
left and right sided heart failure.
 The heart failure is associated with atrioventricular-valve
regurgitation.
 Endomyocardial fibrosis is a major cause of illness and
death in areas where it is endemic, and in its severest form
carries a very poor prognosis, with an estimated survival of
2 years after diagnosis.
HISTORY
 1946: Bedford and Konstam described a form of heart
disease in 40 West African soldiers -post-mortem revealed
subendocardial fibrosis with features that are now
associated with EMF.
 1946: Davies JN first coined the term EMF and said that “he
became convinced rightly or wrongly that he had met a
new disease”.
 1938 : Arthur Williams had described two cases of mitral
incompetence and correlated with large patches of fibrosis
affecting the ventricular walls at necropsy
 1946 : Davies did his MD thesis on this disease where he
described the pathological features as a distinct entity.
 1948 : Bedford encouraged davies to publish his observations and
Arthur Williams and JD Ball were his co-authors.
 Later, JD Ball, with his missionary job joined Christian Medial
College Vellore in India and identified the pathological
specimens at autopsy which he shipped to Davies for
confirmation.
Thus, the disease was reported from India for the first time
 1954 : Davies described the classical four pathological features of
EMF and its distribution in Africa.
Right and left ventricular endocardial fibrosis, affecting the apex
and inflow region with atrioventricular valve regurgitations
The disease came to be known as the Davies’ disease.
 1960 : Samuel and Anklesaria published this initial autopsy
series from south India.
 1962 : CK Gopi from Trivandrum, described the specimen
kept in the hospital autopsied in 1950s as a case of right
ventricular endomyocardial fibrosis with right atrial
thrombi.
EPIDEMIOLOGY
 EMF is a disorder found typically in tropical and
subtropical Africa, notably in Uganda, Nigeria, and
Mozambique
 Major cause of morbidity and mortality, accounting for
25% of cases of congestive heart failure and death in
equatorial Africa.
 A population-based study in rural Mozambique revealed a
prevalence of the disorder affecting 19.8% of the
population.
 The disease is increasingly recognized in other tropical and
subtropical regions within 15 degrees of the equator,
including India, Brazil, Colombia, and Sri Lanka.
 Increased incidence among individuals of low socioeconomic status.
 Male preponderance, is most common in children and young
adults, but has been described in individuals into the sixth decade of
life .
ETIOLOGY
 The cause of the underlying fibrotic process of EMF is largely
unknown; however, several theories exist and are briefly
reviewed
Eosinophilia
 Most commonly cited etiologic link in EMF.
 In support - observed that EMF resembles a late stage of
Loeffler's endocarditis (eosinophilic myocarditis) , a process
known to result from sustained eosinophilia in patients with
hypereosinophilic syndrome .
 EMF and intraventricular thrombosis have also been observed
following a variety of other eosinophilic syndromes including
hypersensitivity myocarditis , parasitic infections , eosinophilic
leukemia, sarcoma, carcinoma, and lymphoma .
 Despite the similarities between Loeffler’s endocarditis and
EMF, serum and myocardial eosinophilia have not been
consistently demonstrated in EMF.
 one study from Uganda found - 60 % of patients with EMF
had at least mild eosinophilia at the time of diagnosis
compared to 10 % of controls , in Kerala, India, most with
EMF did not have active eosinophilia at the time of
diagnosis.
 Endomyocardial biopsies have not demonstrated
eosinophilia in EMF, even in those suspected to have early
disease .
Infectious
 Several infections - toxoplasmosis , rheumatic fever , malaria , and
helminthic parasites .
 A consistent association with one organism, however, has not been
demonstrated.
Environmental exposure
 Cerium, a rare earth element, has been postulated to play a role in the
pathogenesis of EMF.
 Serum levels of cerium are high in patients with EMF compared to
controls, and it is postulated that cerium is ingested from food and
contaminated soil .
 The incidence of EMF is decreasing in India, which corresponds with a
reduction in soil cerium that has occurred with modernization.
Immunologic
 The presence of anti-myosin autoantibodies has been
demonstrated in EMF; however, these antibodies can be
detected in other forms of heart disease such as Dresser’s
syndrome, rheumatic heart disease, and in patients with
post-transplant rejection.
Genetic
 A familial link has been identified in many studies;
however, it is not known whether this is due to an
environmental or genetic cause or both.
PATHOLOGY
 EMF affects both the right and left ventricles in
approximately 50% of patients, purely the left in 40%, and
the right ventricle alone in the remaining 10%.
 The typical gross appearance is that of a normal to slightly
enlarged heart.
 The right atrium may be dilated in proportion to the
severity of right ventricular involvement.
 The hallmark feature of the disorder is fibrotic obliteration
of the apex of the affected ventricle .
 The fibrosis involves the papillary muscles and chordae
tendineae, leading to atrioventricular valve distortion and
regurgitation.
 In the left ventricle, the fibrosis extends from the apex to
the posterior mitral valve leaflet, usually sparing the
anterior mitral leaflet and the ventricular outflow tract.
 Endocardial calcific deposits can be present involving
diffuse areas of the ventricle.
 The fibrotic tissue often creates a nidus for thrombus
formation, which can be extensive. Atrial thrombi also
occur.
 The process usually does not involve the epicardium, and
the coronary artery obstruction is distinctly uncommon.
End-stage endomyocardial disease . Apical ventricular thrombi form in damaged
endocardium, and progressive endomyocardial fibrosis entraps the chordae
tendineae, leading to mitral and sometimes tricuspid valvular incompetence.
(Courtesy Murray Resnick, MD, PhD, Brown University, Providence, RI.)
HISTOLOGY
Histology demonstrates marked fibrotic thickening of the endocardium (arrow), with
proliferation of fibrous tissue in the underlying myocardium, which is consistent with
endomyocardial fibrosis (Masson trichrome stain, original magnification Ă—50).
CLINICAL FEATURES
 The clinical presentation of EMF depends on the chamber
involved, the location of the fibrotic lesion and its severity.
 Davies described three phases of the disease in his
patients from Uganda.
 The initial phase is an acute carditis phase, characterized
by febrile illness and in severe cases with heart failure and
shock.
 Those who survive this acute illness, progress into a sub
acute phase followed by a chronic phase.
 Most of the patients come to clinical attention in this
chronic burnt-out phase
Right Ventricular Endomyocardial Fibrosis
 In pure or predominant right ventricular involvement, the
right ventricular apex is characterized by fibrous
obliteration, which may extend to involve the supporting
structures of the tricuspid valve, with ensuing tricuspid
regurgitation.
 Patients exhibit an elevated JVP, a prominent v wave with
rapid y descent, and a right-sided S3 gallop.
 There is prominent hepatomegaly with a pulsatile liver,
ascites, splenomegaly, and peripheral edema, but
pulmonary congestion is typically absent because of the
lack of left-sided involvement.
Left Ventricular Endomyocardial Fibrosis
 In cases of predominant left-sided disease, fibrosis involves
the ventricular apex and often the chordae tendineae or the
posterior mitral valve leaflet, producing mitral
regurgitation.
 The associated murmur may be late systolic, characteristic
of a papillary muscle dysfunction murmur, or pansystolic.
 Findings of pulmonary hypertension may be prominent,
and an S3protodiastolic gallop is frequently present.
Biventricular Endomyocardial Fibrosis
 Biventricular EMF is more common then either isolated
right- or left-sided disease.
 The typical clinical presentation of EMF resembles right
ventricular EMF; however, a murmur of mitral
regurgitation is indicative of left-sided involvement.
 Unless left ventricular involvement is extensive, severe
pulmonary hypertension is absent and the right-sided
findings are the predominant mode of presentation.
 Approximately 15% of patients will experience systemic
embolization, and only 2% will have infective endocarditis.
 In a study conducted in india which included 145 pts with EMF
show clinical profile
 The mean (SD) age of the patients at first presentation was 26±3
(14±1) years for women (n = 70) and 21±1 (11±9) years for men (n
= 75); 33.1% were under 15.
Gupta PN, Valiathan MS, Balakrishnan KG,
Kartha CC, Ghosh MK. Clinical course of
endomyocardial fibrosis. Br Heart
J. 1989;62:450–4.
Sree
Chitra Tirunal Institute for Medical
Sciences and Technology,
Trivandrum 69501 1, Kerala, Indi
A COMPARISON OF THE CLINICAL AND CARDIOLOGICAL
FEATURES OF ENDOMYOCARDIAL DISEASE IN
TEMPERATE AND TROPICAL REGIONS
J. DAVIES ,G. VIJAYARAGHAVAN et al A comparison of the clinical and cardiological
features of endomyocardial disease in
temperate and tropical regions,1983.
J. DAVIES ,G. VIJAYARAGHAVAN et al A comparison of the
clinical and cardiological features of endomyocardial disease in
temperate and tropical regions,1983.
RV EMF
 Right atrial (RA) abnormality - peaking and increased P wave
amplitude in lead II
Tharakan J. Electrocardiogram in endomyocardial fibrosis. Indian J
Pacing Electrophysiol.2011;11:129–33
ECG
DIAGNOSIS
 QR pattern with a diminutive R wave in lead V1 , attributed to RA
enlargement, though this pattern is seen even in patients with atrial
fibrillation (AF) .
Tharakan J. Electrocardiogram in endomyocardial fibrosis. Indian J
Pacing Electrophysiol.2011;11:129–33
 In isolated RV EMF - A dominant R wave in V2 in the absence of QR
pattern in V1 in 14 of 25 patients resulting in early transition from a
dominant S wave in right sided chest leads to dominant R wave in V2 or
earlier .
Tharakan J. Electrocardiogram in endomyocardial fibrosis. Indian J
Pacing Electrophysiol.2011;11:129–33
 AF is seen in the end stage patients with advanced
RV EMF.
 It is noteworthy that patients with RV EMF and AF
rarely have fast ventricular response, in striking
contrast to patients with AF and LV EMF.
 Patients with large pericardial effusion often have
low voltage QRS, satisfying the low voltage ECG
criteria.
LV EMF
 LA abnormality.
 AF occurs in advanced and uncorrected case of LVEMF.
 The odd finding is a uniform ST segment depression and T
wave inversion more evident in the lateral chest leads,
similar to apical hypertrophic cardiomyopathy (HCM) and
non- ST elevation acute coronary syndromes
Tharakan J. Electrocardiogram in endomyocardial fibrosis. Indian J
Pacing Electrophysiol.2011;11:129–33
 More than 50% patients with EMF have biventricular
involvement
 The ECG reflects a combination of these abnormalities.
 ECG findings reported by Balakrishnan et al from Sree
Chitra Tirunal Institute for Medical Sciences and
Technology, Trivandrum - 210 patients
 AF (33%), junctional rhythm or heart block (4.4%), right
axis deviation (29%), intra ventricular conduction
abnormality (16%) and atrial tachycardia or atrial
flutter(3.5%).
Balakrishnan KG, et al. Clinical course of patients in Kerala. In: Valiathan MS,
editor.Endomyocardial fibrosis. Oxford University Press; 1993
 Earlier three large studies of 60 patients, 95 patients
and 50 patients, reported AF in 40%, junctional
rhythm in 2%, RA enlargement in 32% and QR pattern
in V1 in 25% patients .
 LA enlargement was common in patients with LVEMF
and 18% of LVEMF patients had LVH (left ventricular
hypertrophy) with strain .
Sapru RP. Clinical profile of endomyocardial fibrosis. In: Sapru RP,
editor. Endomyocardial fibrosis in India. ICMR; 1983.
Vijayaraghavan G, et al. Endomyocardial fibrosis: Clinical, ECG and
radiological features. In: Sapru RP, editor. Endomyocardial fibrosis in
India. ICMR; 1983.
Jacob G, et al. Endomyocardial fibrosis in Kerala. In: Sapru RP,
editor. Endomyocardial fibrosis in India. ICMR; 1983.
Jacob G, et al. Endomyocardial fibrosis in Kerala. In: Sapru RP,
editor. Endomyocardial fibrosis in India. ICMR; 1983
Echocardiography
 Apical fibrosis of the right ventricle (RV), left ventricle (LV), or
both ventricles.
 Tethering the atrioventricular (AV) valve papillary muscles,
leading to mitral and/or tricuspid regurgitation
 Giant atrial enlargement .
 Restrictive filling pattern on Doppler recordings of mitral valve
inflow .
 Apical thrombi are often present
 In a study conducted in brazil - 12 pts with EMF were studied
with Doppler echocardiography with the purpose of describing
the echocardiographic features and identify the affected sites.
 The average age was 41 years (range 16 to 59 years), 2 men and 10
women.
 3 (25%) had isolated right ventricular involvement, one patient
(8%) left ventricular, 8 patients (66%) both ventricular.
 Doppler echocardiographic findings were: right atrium
enlargement (91%), right ventricle outflow dilatation (83%),
paradoxical septal motion (83%), left atrial enlargement (33%),
mitral and tricuspid valve prolapse (50%), pericardial effusion
(41%), mitral regurgitation (75%), tricuspid regurgitation
(100%), apex obliteration (50%) and a restrictive type flow
pattern (50%).
Tello r Cuan et al . Doppler echocardiography in endomyocardial fibrosis
, Brazil ,1994.
 In a study conducted in india which included 145 pts
with EMF ,Echocardiographic data were available in
86 patients.
 The mean (SD) left ventricular internal dimensions
in diastole and systole were 4.17 (1.19) cm and 2.9 (1.
07) cm respectively.
 Pericardial effusion was present in 35 (40.7%),
intracavitary thrombi in 11 (12.8%), and myocardial
calcification in 16 (18. 6%) patients.
Gupta PN, Valiathan MS, Balakrishnan KG, Kartha CC, Ghosh MK. Clinical
course of endomyocardial fibrosis. Br Heart J. 1989;62:450–4. Sree
Chitra Tirunal Institute for Medical Sciences and Technology,
Trivandrum 69501 1, Kerala, India
 An echocardiographic screening study in Mozambique
included echocardiographic criteria for the diagnosis and
staging of EMF
 As the natural history of EMF is not well defined, these
criteria will likely aid in defining the stages of this disease
and in determining the clinical significance of early EMF.
Classification of Endomyocardial
Fibrosis
 They defined major and minor criteria for the diagnosis of EMF
on the basis of features of advanced disease and pathologic
features of early stages described in postmortem studies.
 Endomyocardial fibrosis was diagnosed in the presence of two
major criteria or one major criterion associated with two minor
criteria
 Possible scores ranged from 0 to 35; cases with
ď‚— scores of 8 or less were classified as mild,
ď‚— scores of 8 to 15 as moderate,
ď‚— scores of 15 or more as severe.
A Population Study of Endomyocardial Fibrosis in a Rural Area of Mozambique Ana Olga Mocumbi, M.D.,
Maria Beatriz Ferreira, M.D., Ph.D., Daniel Sidi, M.D., Ph.D., and Magdi H. Yacoub, F.R.S. N Engl J Med
2008;359:43-9.
HEMODYNAMIC FINDINGS
 The typical haemodynamic finding on cardiac
catheterization is the dip and plateau pattern of
restrictive ventricular filling.
 In a study conducted in
Mozambique included 21
pts showed
 In patients with RV EMF,
RA pressure was increased
with prominent A waves,
which was also seen in the
right ventricular and
pulmonary artery pressure
tracings .
 The right ventricular
pressure tracing showed a
dip and high end-diastolic
pressure 5 mm Hg higher
than the pulmonary
diastolic pressure, and the
contour of the right
ventricular pressure
tracing was distorted .
 In patients with left
sided involvement, left
ventricular end-
diastolic pressure was
very high.
 A dip and plateau
pattern of the
ventricular pressure
curve present .
 Pulmonary
hypertension present
in all patients with left
and biventricular EMF
 In a study conducted which included 8 pts, their
hemodynamics showed
Vijayaraghavan G, Cherian G, Krishnaswami S, Sukumar IP. Left
ventricular endomyocardial fibrosis in India. Br Heart J. 1977;39:563–8
Gupta PN, Valiathan MS, Balakrishnan KG, Kartha CC, Ghosh MK. Clinical
course of endomyocardial fibrosis. Br Heart J. 1989;62:450–4. Sree
Chitra Tirunal Institute for Medical Sciences and Technology,
Trivandrum 69501 1, Kerala, India
Chest X-Ray
 Cardiomegaly - varying degrees from mild to severe.
 Right atrial enlargement in the patients with right-sided
involvement, left atrial enlargement in patients with left-
sided involvement, and biatrial enlargement in those with
biventricular involvement.
 Pulmonary venous congestion with left-sided involvement.
 Endocardial calcification
Somers K, Williams AW. Intracardiac calcification in endomyocardial
fibrosis. Br Heart J.1962;24:324–8
Vijayaraghavan G, Cherian G, Krishnaswami S, Sukumar IP. Left ventricular
endomyocardial fibrosis in India. Br Heart J. 1977;39:563–8
ANGIOGRAPHY
CHARACTERISTIC OBLITERATION OF THE APEX OF THE INVOLVED VENTRICLE(S)
WITH VARYING DEGREE OF AV VALVE REGURGITATION
Left ventricular angiogram in the RAO view showing obliteration of the apex
(arrow) in systole (top, a) and diastole (bottom, b).
Walid M. Hassan, MD, FCCP; Mohamed et al Pitfalls in Diagnosis and Clinical, Echocardiographic, and
Hemodynamic Findings in Endomyocardial Fibrosis A 25-Year Experience 2005
Right ventricular angiogram in the RAO view in a patient with right-sided EMF
showing complete obliteration of the apex of the right ventricle, dilated right
atrium, and severe TR. .
Walid M. Hassan, MD, FCCP; Mohamed et al Pitfalls in Diagnosis and Clinical, Echocardiographic, and
Hemodynamic Findings in Endomyocardial Fibrosis A 25-Year Experience 2005
 CMR imaging with
contrast demonstrates
myocardial fibrosis.
 In early disease where
there is suspicion for
active inflammation, CMR
may be useful in
identifying patients who
may benefit from steroid
therapy
Cardiovascular magnetic resonance imaging
CT SCAN
Endomyocardial Biopsy
Photomicrograph of endomyocardial biopsy specimen
showing marked thickening of the endocardium (E) with fibrosis
(hematoxylin-eosin, original Ă— 200).
MANAGEMENT
Medical therapy
 Remains challenging.
 One third to one half of patients with advanced disease die
within 2 years
 Atrial fibrillation is a poor prognostic indicator, although
symptomatic relief can be achieved with rate control
 Heart failure - difficult to control, and diuretics are effective only
in early stages of disease, losing efficacy with advanced ascites.
Surgery
 Endomyocardial resection - endocardectomy with valve
replacement or repair - especially in subjects in advanced heart
failure
 Immediate postoperative mortality is high - 15 to 30 %.
 A surgical series of 83 patients from Brazil all in NYHA class
grade III to IV, and with a mean follow-up of 7.6 years had a
survival probability at 17 years of 55 percent .
ď‚— 4 (5.8%) patients - recurrence of the fibrosis and were reoperated on
and in 6 (8.8%), EMF appeared in the other ventricle.
ď‚— 5 (7.3%) patients were reoperated on to replace either a valve prosthesis
or a native valve which had been preserved during the first procedure.
ď‚— Only 24 (45%) of the 53 surviving patients are in functional class I or II.
Fernando Moraes , Cleuza et al Surgery for endomyocardial fibrosis
revisited September 1998
 Published series have been small, overall experience
is limited, and questions remain about the
appropriate timing, peri-operative mortality, and
long-term prognosis .
Left ventricular angiogram in the RAO view showing a small left ventricle
with apical obliteration,severe MR, and dilated left atrium in a patient with
left-sided EMF (top, a) and after surgery with endocardectomy
and mitral valve replacement (bottom, b).
Fernando Moraes , Cleuza et al Surgery for endomyocardial fibrosis
revisited September 1998
CLINICAL COURSE
 The factors significantly affecting survival were
Gupta PN, Valiathan MS, Balakrishnan KG, Kartha CC, Ghosh MK. Clinical
course of endomyocardial fibrosis. Br Heart J. 1989;62:450–4. Sree
Chitra Tirunal Institute for Medical Sciences and Technology,
Trivandrum 69501 1, Kerala, India
Gupta PN, Valiathan MS, Balakrishnan KG, Kartha CC, Ghosh MK. Clinical course of
endomyocardial fibrosis. Br Heart J. 1989;62:450–4. Sree
Chitra Tirunal Institute for Medical Sciences and Technology,
Trivandrum 69501 1, Kerala, India
Changing natural history of endomyocardial fibrosis
 Gupta and colleagues defined the natural history of the
disease in Kerala in the late 1980s.
 Follow up of the initial 200 patients showed a 10 year
survival of only 37 %.
 Ascites, atrial fibrillation and NYHA class IV were the poor
prognostic indicators.
 Eighty nine patients, who underwent endocardiectomy
with MVR had an actuarial survival of 55 % during the
same period.
 Significant decline in the number of new cases happened
in the hospital admissions in Kerala in the subsequent
decades.
 Natural history in them was more favourable with less than
10 per cent mortality on seven years follow up.
 The average number of cases seen declined by half in the
last decade, compared to the previous decade.
 The mean age of the patients seen is now 33 yr compared to
25 yr in the previous decade, suggesting that people who
were asymptomatic in the previous era are now being
picked up on evaluation.
 There are no patients below 10 yr, whereas in the previous
decade, 28 per cent were below the age of 15 yr.
 The patients are less symptomatic and older.
 The majority are incidentally diagnosed when evaluated for
electrocardiographic or echocardiographic abnormalities.
 Temporal correlates of this changing natural history are worth
analyzing.
 The period noted in the natural history studies belong to the 30 year
period of 1976 to 2007
 Kerala witnessed substantial economic, nutritional and health
transitions.
 Cassava and plantain are no longer the staple diet for the Keralites.
 The per capita calorie consumption increased from 1600 to 2100 Kcals.
 The nutritional deficiency disorders were replaced by those of over
nutrition and currently, Kerala is the diabetic capital for India.
 Thanks to the good female literacy, health status of Kerala is acclaimed
as an example for good health at low cost.
 A community survey shows that there is a substantial decline in
worm load per child.
 Filarial endemicity continues to be little less, with rigorous
governmental programmes initiated for its control.
 Eosinophilia in children is now uncommon.
 There is substantial decline in rheumatic fever and rheumatic
heart disease in children of Kerala correlating with the improved
health care services and quality of life.
 The question which needs to be answered now is what really
caused this decline; is it the change in living standards, or
change in the dietary pattern or the reduction in childhood
infections? By and large, endomyocardial fibrosis could be a
reaction pattern of the endocardium to a variety of insults
 Presence of interstitial fibrosis, myohypertrophy, and calcification
speaks of the role of cytokines in its genesis.
 Predominant right ventricular involvement in children could indicate
an insult when the right ventricle could be more susceptible.
 Right ventricle receives most of the umbilical venous return in utero
and is more dominant.
 But no antenatal cases are reported till date and the youngest report is
that of a 4 month old baby.
 The inflammatory response occurring in the younger age group could
manifest as calcification in later years.
 Whether this calcification has its similarity to vascular and valvar
calcium occurring in older age group; if so, could it be the factor which
holds the key for unraveling this mystery?
SUMMARY
 EMF is a restrictive cardiomyopathy observed in the tropics usually at
the end-stage of the disease.
 It may be indistinguishable from Loeffler’s endocarditis, observed in
temperate climates.
 The pathogenesis remains unknown; however, eosinophilia may play a
role.
 Echocardiography may show uni- or bilateral ventricular apex
obliteration with severely dilated atria and a restrictive filling pattern.
 The prognosis is poor, with a mortality estimated at 25 % per year.
 Surgical treatment with endomyocardial resection and valve
replacement may be beneficial in patients with advanced apical
obliteration and sever heart failure symptoms.

Weitere ähnliche Inhalte

Was ist angesagt?

Aortic regurgitation
Aortic regurgitationAortic regurgitation
Aortic regurgitationPratap Tiwari
 
Constrictive pericarditis
Constrictive pericarditis Constrictive pericarditis
Constrictive pericarditis Ramachandra Barik
 
Aortic dissection nikku ppt
Aortic dissection nikku pptAortic dissection nikku ppt
Aortic dissection nikku pptNikhil Vaishnav
 
dialated cardiomyopathies
dialated cardiomyopathiesdialated cardiomyopathies
dialated cardiomyopathiesAbhay Mange
 
Sudden cardiac death
Sudden cardiac deathSudden cardiac death
Sudden cardiac deathSunil Reddy D
 
Left Bundle Branch Block (LBBB)
Left Bundle Branch Block (LBBB)Left Bundle Branch Block (LBBB)
Left Bundle Branch Block (LBBB)Kerolus Shehata
 
Ventricular septal defect VSD . Firas Aljanadi-Oct 2019
Ventricular septal defect VSD . Firas Aljanadi-Oct 2019Ventricular septal defect VSD . Firas Aljanadi-Oct 2019
Ventricular septal defect VSD . Firas Aljanadi-Oct 2019FIRAS ALJANADI
 
Takotsubo Cardiomyopathy
Takotsubo CardiomyopathyTakotsubo Cardiomyopathy
Takotsubo Cardiomyopathymeducationdotnet
 
Localization of WPW( accessory Pathway) by surface ECG
Localization of WPW( accessory Pathway) by surface ECGLocalization of WPW( accessory Pathway) by surface ECG
Localization of WPW( accessory Pathway) by surface ECGRaghu Kishore Galla
 
Pericardial diseases
Pericardial diseasesPericardial diseases
Pericardial diseasesimrana tanvir
 
Takayasu's arteritis
Takayasu's arteritisTakayasu's arteritis
Takayasu's arteritisAnkur Gupta
 
Eisenmenger syndrome
Eisenmenger syndromeEisenmenger syndrome
Eisenmenger syndromeFuad Farooq
 
reversible cardiomyopathies
reversible cardiomyopathiesreversible cardiomyopathies
reversible cardiomyopathiesShivani Rao
 
Constrictive pericarditis
Constrictive pericarditisConstrictive pericarditis
Constrictive pericarditisWaqas Khalid
 
Dilated cardiomyopathy
Dilated cardiomyopathyDilated cardiomyopathy
Dilated cardiomyopathyAvinash Arke
 
Coarctation of aorta
Coarctation of aortaCoarctation of aorta
Coarctation of aortaS. Ismat
 
Echo in restrictive cardiomyopathy
Echo in restrictive cardiomyopathyEcho in restrictive cardiomyopathy
Echo in restrictive cardiomyopathysruthiMeenaxshiSR
 

Was ist angesagt? (20)

Aortic regurgitation
Aortic regurgitationAortic regurgitation
Aortic regurgitation
 
Constrictive pericarditis
Constrictive pericarditis Constrictive pericarditis
Constrictive pericarditis
 
Aortic dissection nikku ppt
Aortic dissection nikku pptAortic dissection nikku ppt
Aortic dissection nikku ppt
 
EBSTEIN ANOMALY
EBSTEIN ANOMALYEBSTEIN ANOMALY
EBSTEIN ANOMALY
 
HOCM Hypertrophic cardiomyopathy
HOCM Hypertrophic cardiomyopathyHOCM Hypertrophic cardiomyopathy
HOCM Hypertrophic cardiomyopathy
 
dialated cardiomyopathies
dialated cardiomyopathiesdialated cardiomyopathies
dialated cardiomyopathies
 
Sudden cardiac death
Sudden cardiac deathSudden cardiac death
Sudden cardiac death
 
Left Bundle Branch Block (LBBB)
Left Bundle Branch Block (LBBB)Left Bundle Branch Block (LBBB)
Left Bundle Branch Block (LBBB)
 
Ventricular septal defect VSD . Firas Aljanadi-Oct 2019
Ventricular septal defect VSD . Firas Aljanadi-Oct 2019Ventricular septal defect VSD . Firas Aljanadi-Oct 2019
Ventricular septal defect VSD . Firas Aljanadi-Oct 2019
 
Takotsubo Cardiomyopathy
Takotsubo CardiomyopathyTakotsubo Cardiomyopathy
Takotsubo Cardiomyopathy
 
Localization of WPW( accessory Pathway) by surface ECG
Localization of WPW( accessory Pathway) by surface ECGLocalization of WPW( accessory Pathway) by surface ECG
Localization of WPW( accessory Pathway) by surface ECG
 
Pericardial diseases
Pericardial diseasesPericardial diseases
Pericardial diseases
 
Takayasu's arteritis
Takayasu's arteritisTakayasu's arteritis
Takayasu's arteritis
 
Eisenmenger syndrome
Eisenmenger syndromeEisenmenger syndrome
Eisenmenger syndrome
 
reversible cardiomyopathies
reversible cardiomyopathiesreversible cardiomyopathies
reversible cardiomyopathies
 
Constrictive pericarditis
Constrictive pericarditisConstrictive pericarditis
Constrictive pericarditis
 
Dilated cardiomyopathy
Dilated cardiomyopathyDilated cardiomyopathy
Dilated cardiomyopathy
 
ATRIOVENTRICULAR SEPTAL DEFECT
ATRIOVENTRICULAR SEPTAL DEFECTATRIOVENTRICULAR SEPTAL DEFECT
ATRIOVENTRICULAR SEPTAL DEFECT
 
Coarctation of aorta
Coarctation of aortaCoarctation of aorta
Coarctation of aorta
 
Echo in restrictive cardiomyopathy
Echo in restrictive cardiomyopathyEcho in restrictive cardiomyopathy
Echo in restrictive cardiomyopathy
 

Ă„hnlich wie ENDOMYOCARDIAL FIBROSIS

ENDOMYOCARDIAL FIBROSIS BY MIEBAKA FAITHFUL DANIEL.pptx
ENDOMYOCARDIAL FIBROSIS BY MIEBAKA FAITHFUL DANIEL.pptxENDOMYOCARDIAL FIBROSIS BY MIEBAKA FAITHFUL DANIEL.pptx
ENDOMYOCARDIAL FIBROSIS BY MIEBAKA FAITHFUL DANIEL.pptxDanielFaithful
 
Arrhythmogenic right ventricular 2003
Arrhythmogenic right ventricular 2003Arrhythmogenic right ventricular 2003
Arrhythmogenic right ventricular 2003PGI Pathology Residents
 
Complicated Tubercular Pericarditis Presenting as Ventricular Apical Aneurysm...
Complicated Tubercular Pericarditis Presenting as Ventricular Apical Aneurysm...Complicated Tubercular Pericarditis Presenting as Ventricular Apical Aneurysm...
Complicated Tubercular Pericarditis Presenting as Ventricular Apical Aneurysm...Crimsonpublisherssmoaj
 
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower LimbMeadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower Limbsemualkaira
 
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower LimbMeadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower Limbsemualkaira
 
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower LimbMeadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower Limbsemualkaira
 
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower LimbMeadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower Limbsemualkaira
 
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower LimbMeadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower Limbsemualkaira
 
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower LimbMeadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower Limbsemualkaira
 
Occurrence of Lutembacher syndrome in a rural regional hospital: case report ...
Occurrence of Lutembacher syndrome in a rural regional hospital: case report ...Occurrence of Lutembacher syndrome in a rural regional hospital: case report ...
Occurrence of Lutembacher syndrome in a rural regional hospital: case report ...Cardiovascular Diagnosis and Therapy (CDT)
 
cerebral vascular malformation
cerebral vascular malformationcerebral vascular malformation
cerebral vascular malformationMojtabaKhazaei2
 
Congenital heart diseases
Congenital heart diseasesCongenital heart diseases
Congenital heart diseasesMWIZERWA JEAN-LUC
 
Endocarditis review
Endocarditis reviewEndocarditis review
Endocarditis reviewscott homann
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective EndocarditisKerolus Shehata
 
A Rare Case of Hypertrophic Cardiomyopathy Associated with Congenital Mitral ...
A Rare Case of Hypertrophic Cardiomyopathy Associated with Congenital Mitral ...A Rare Case of Hypertrophic Cardiomyopathy Associated with Congenital Mitral ...
A Rare Case of Hypertrophic Cardiomyopathy Associated with Congenital Mitral ...asclepiuspdfs
 
Central Nervous System Histoplasmosis Related to Bioprosthetic Endocarditis
Central Nervous System Histoplasmosis Related to Bioprosthetic EndocarditisCentral Nervous System Histoplasmosis Related to Bioprosthetic Endocarditis
Central Nervous System Histoplasmosis Related to Bioprosthetic Endocarditisasclepiuspdfs
 
Med jdy patiluniv_2016_9_4_541_186077
Med jdy patiluniv_2016_9_4_541_186077Med jdy patiluniv_2016_9_4_541_186077
Med jdy patiluniv_2016_9_4_541_186077Keshri Yadav
 

Ă„hnlich wie ENDOMYOCARDIAL FIBROSIS (20)

Emf final present
Emf final presentEmf final present
Emf final present
 
ENDOMYOCARDIAL FIBROSIS BY MIEBAKA FAITHFUL DANIEL.pptx
ENDOMYOCARDIAL FIBROSIS BY MIEBAKA FAITHFUL DANIEL.pptxENDOMYOCARDIAL FIBROSIS BY MIEBAKA FAITHFUL DANIEL.pptx
ENDOMYOCARDIAL FIBROSIS BY MIEBAKA FAITHFUL DANIEL.pptx
 
Arrhythmogenic right ventricular 2003
Arrhythmogenic right ventricular 2003Arrhythmogenic right ventricular 2003
Arrhythmogenic right ventricular 2003
 
Complicated Tubercular Pericarditis Presenting as Ventricular Apical Aneurysm...
Complicated Tubercular Pericarditis Presenting as Ventricular Apical Aneurysm...Complicated Tubercular Pericarditis Presenting as Ventricular Apical Aneurysm...
Complicated Tubercular Pericarditis Presenting as Ventricular Apical Aneurysm...
 
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower LimbMeadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
 
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower LimbMeadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
 
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower LimbMeadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
 
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower LimbMeadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
 
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower LimbMeadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
 
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower LimbMeadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
Meadows Syndrome as Manifested by Displaced Ischemia of the Lower Limb
 
Occurrence of Lutembacher syndrome in a rural regional hospital: case report ...
Occurrence of Lutembacher syndrome in a rural regional hospital: case report ...Occurrence of Lutembacher syndrome in a rural regional hospital: case report ...
Occurrence of Lutembacher syndrome in a rural regional hospital: case report ...
 
cerebral vascular malformation
cerebral vascular malformationcerebral vascular malformation
cerebral vascular malformation
 
Congenital heart diseases
Congenital heart diseasesCongenital heart diseases
Congenital heart diseases
 
Ventricular fibrillation eMedicine Article
Ventricular fibrillation eMedicine ArticleVentricular fibrillation eMedicine Article
Ventricular fibrillation eMedicine Article
 
Acyanotic heart diseases
Acyanotic heart diseasesAcyanotic heart diseases
Acyanotic heart diseases
 
Endocarditis review
Endocarditis reviewEndocarditis review
Endocarditis review
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective Endocarditis
 
A Rare Case of Hypertrophic Cardiomyopathy Associated with Congenital Mitral ...
A Rare Case of Hypertrophic Cardiomyopathy Associated with Congenital Mitral ...A Rare Case of Hypertrophic Cardiomyopathy Associated with Congenital Mitral ...
A Rare Case of Hypertrophic Cardiomyopathy Associated with Congenital Mitral ...
 
Central Nervous System Histoplasmosis Related to Bioprosthetic Endocarditis
Central Nervous System Histoplasmosis Related to Bioprosthetic EndocarditisCentral Nervous System Histoplasmosis Related to Bioprosthetic Endocarditis
Central Nervous System Histoplasmosis Related to Bioprosthetic Endocarditis
 
Med jdy patiluniv_2016_9_4_541_186077
Med jdy patiluniv_2016_9_4_541_186077Med jdy patiluniv_2016_9_4_541_186077
Med jdy patiluniv_2016_9_4_541_186077
 

Mehr von Vishwanath Hesarur

Treatment strategies in patients with statin intolerance
Treatment strategies in patients with statin intoleranceTreatment strategies in patients with statin intolerance
Treatment strategies in patients with statin intoleranceVishwanath Hesarur
 
The age, creatinine, and ejection fraction score to risk
The age, creatinine, and ejection fraction score to riskThe age, creatinine, and ejection fraction score to risk
The age, creatinine, and ejection fraction score to riskVishwanath Hesarur
 
Riociguat for the treatment of pah
Riociguat for the treatment of pahRiociguat for the treatment of pah
Riociguat for the treatment of pahVishwanath Hesarur
 
Radiation dose reduction
Radiation dose reduction Radiation dose reduction
Radiation dose reduction Vishwanath Hesarur
 
Pre hospital reduced-dose fibrinolysis followed by pci
Pre hospital reduced-dose fibrinolysis followed by pciPre hospital reduced-dose fibrinolysis followed by pci
Pre hospital reduced-dose fibrinolysis followed by pciVishwanath Hesarur
 
Monocyte chemoattractant protein 1
Monocyte chemoattractant protein 1Monocyte chemoattractant protein 1
Monocyte chemoattractant protein 1Vishwanath Hesarur
 
CHRONIC ASPIRIN AND STATIN THERAPY IN PATIENTS WITH IMPAIRED RENAL FUNCTION A...
CHRONIC ASPIRIN AND STATIN THERAPYIN PATIENTS WITH IMPAIRED RENAL FUNCTIONA...CHRONIC ASPIRIN AND STATIN THERAPYIN PATIENTS WITH IMPAIRED RENAL FUNCTIONA...
CHRONIC ASPIRIN AND STATIN THERAPY IN PATIENTS WITH IMPAIRED RENAL FUNCTION A...Vishwanath Hesarur
 
Bivalirudin in acute coronary syndromes and percutaneous coronary
Bivalirudin in acute coronary syndromes and percutaneous coronaryBivalirudin in acute coronary syndromes and percutaneous coronary
Bivalirudin in acute coronary syndromes and percutaneous coronaryVishwanath Hesarur
 
CARDIOVASCULAR DISEASE AND DIABETES
CARDIOVASCULAR DISEASE AND DIABETESCARDIOVASCULAR DISEASE AND DIABETES
CARDIOVASCULAR DISEASE AND DIABETESVishwanath Hesarur
 
TOTAL ANOMALOUS PULMONARY VENOUS CONNECTION (TAPVC)
TOTAL ANOMALOUS PULMONARY VENOUS CONNECTION (TAPVC)TOTAL ANOMALOUS PULMONARY VENOUS CONNECTION (TAPVC)
TOTAL ANOMALOUS PULMONARY VENOUS CONNECTION (TAPVC)Vishwanath Hesarur
 

Mehr von Vishwanath Hesarur (18)

Treatment strategies in patients with statin intolerance
Treatment strategies in patients with statin intoleranceTreatment strategies in patients with statin intolerance
Treatment strategies in patients with statin intolerance
 
The age, creatinine, and ejection fraction score to risk
The age, creatinine, and ejection fraction score to riskThe age, creatinine, and ejection fraction score to risk
The age, creatinine, and ejection fraction score to risk
 
Riociguat for the treatment of pah
Riociguat for the treatment of pahRiociguat for the treatment of pah
Riociguat for the treatment of pah
 
Radiation dose reduction
Radiation dose reduction Radiation dose reduction
Radiation dose reduction
 
Pre hospital reduced-dose fibrinolysis followed by pci
Pre hospital reduced-dose fibrinolysis followed by pciPre hospital reduced-dose fibrinolysis followed by pci
Pre hospital reduced-dose fibrinolysis followed by pci
 
Nstemi
NstemiNstemi
Nstemi
 
Monocyte chemoattractant protein 1
Monocyte chemoattractant protein 1Monocyte chemoattractant protein 1
Monocyte chemoattractant protein 1
 
Energy drink
Energy drinkEnergy drink
Energy drink
 
Dissolution trial
Dissolution trialDissolution trial
Dissolution trial
 
Defer stemi
Defer stemiDefer stemi
Defer stemi
 
Cvs & t2 dm
Cvs & t2 dmCvs & t2 dm
Cvs & t2 dm
 
CHRONIC ASPIRIN AND STATIN THERAPY IN PATIENTS WITH IMPAIRED RENAL FUNCTION A...
CHRONIC ASPIRIN AND STATIN THERAPYIN PATIENTS WITH IMPAIRED RENAL FUNCTIONA...CHRONIC ASPIRIN AND STATIN THERAPYIN PATIENTS WITH IMPAIRED RENAL FUNCTIONA...
CHRONIC ASPIRIN AND STATIN THERAPY IN PATIENTS WITH IMPAIRED RENAL FUNCTION A...
 
Bivalirudin in acute coronary syndromes and percutaneous coronary
Bivalirudin in acute coronary syndromes and percutaneous coronaryBivalirudin in acute coronary syndromes and percutaneous coronary
Bivalirudin in acute coronary syndromes and percutaneous coronary
 
CARDIOVASCULAR DISEASE AND DIABETES
CARDIOVASCULAR DISEASE AND DIABETESCARDIOVASCULAR DISEASE AND DIABETES
CARDIOVASCULAR DISEASE AND DIABETES
 
FRACTIONAL FLOW RESERVE
FRACTIONAL FLOW RESERVEFRACTIONAL FLOW RESERVE
FRACTIONAL FLOW RESERVE
 
TOTAL ANOMALOUS PULMONARY VENOUS CONNECTION (TAPVC)
TOTAL ANOMALOUS PULMONARY VENOUS CONNECTION (TAPVC)TOTAL ANOMALOUS PULMONARY VENOUS CONNECTION (TAPVC)
TOTAL ANOMALOUS PULMONARY VENOUS CONNECTION (TAPVC)
 
Cardiac transplantation
Cardiac transplantationCardiac transplantation
Cardiac transplantation
 
Truncus Arteriosus
Truncus Arteriosus Truncus Arteriosus
Truncus Arteriosus
 

KĂĽrzlich hochgeladen

Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptxUnlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptxanandsmhk
 
Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)PraveenaKalaiselvan1
 
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral AnalysisRaman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral AnalysisDiwakar Mishra
 
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatidSpermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatidSarthak Sekhar Mondal
 
Work, Energy and Power for class 10 ICSE Physics
Work, Energy and Power for class 10 ICSE PhysicsWork, Energy and Power for class 10 ICSE Physics
Work, Energy and Power for class 10 ICSE Physicsvishikhakeshava1
 
Lucknow đź’‹ Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow đź’‹ Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...Lucknow đź’‹ Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow đź’‹ Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...anilsa9823
 
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCRStunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCRDelhi Call girls
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Lokesh Kothari
 
Biopesticide (2).pptx .This slides helps to know the different types of biop...
Biopesticide (2).pptx  .This slides helps to know the different types of biop...Biopesticide (2).pptx  .This slides helps to know the different types of biop...
Biopesticide (2).pptx .This slides helps to know the different types of biop...RohitNehra6
 
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...jana861314
 
Caco-2 cell permeability assay for drug absorption
Caco-2 cell permeability assay for drug absorptionCaco-2 cell permeability assay for drug absorption
Caco-2 cell permeability assay for drug absorptionPriyansha Singh
 
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bNightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bSĂ©rgio Sacani
 
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.aasikanpl
 
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |aasikanpl
 
Presentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxPresentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxgindu3009
 
A relative description on Sonoporation.pdf
A relative description on Sonoporation.pdfA relative description on Sonoporation.pdf
A relative description on Sonoporation.pdfnehabiju2046
 
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...Sérgio Sacani
 
Orientation, design and principles of polyhouse
Orientation, design and principles of polyhouseOrientation, design and principles of polyhouse
Orientation, design and principles of polyhousejana861314
 
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxAnalytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxSwapnil Therkar
 

KĂĽrzlich hochgeladen (20)

Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptxUnlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
 
Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)
 
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral AnalysisRaman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
Raman spectroscopy.pptx M Pharm, M Sc, Advanced Spectral Analysis
 
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
9953056974 Young Call Girls In Mahavir enclave Indian Quality Escort service
 
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatidSpermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
 
Work, Energy and Power for class 10 ICSE Physics
Work, Energy and Power for class 10 ICSE PhysicsWork, Energy and Power for class 10 ICSE Physics
Work, Energy and Power for class 10 ICSE Physics
 
Lucknow đź’‹ Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow đź’‹ Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...Lucknow đź’‹ Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow đź’‹ Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
 
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCRStunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
Stunning ➥8448380779▻ Call Girls In Panchshil Enclave Delhi NCR
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
 
Biopesticide (2).pptx .This slides helps to know the different types of biop...
Biopesticide (2).pptx  .This slides helps to know the different types of biop...Biopesticide (2).pptx  .This slides helps to know the different types of biop...
Biopesticide (2).pptx .This slides helps to know the different types of biop...
 
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
 
Caco-2 cell permeability assay for drug absorption
Caco-2 cell permeability assay for drug absorptionCaco-2 cell permeability assay for drug absorption
Caco-2 cell permeability assay for drug absorption
 
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bNightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
 
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
 
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
Call Us ≽ 9953322196 ≼ Call Girls In Mukherjee Nagar(Delhi) |
 
Presentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxPresentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptx
 
A relative description on Sonoporation.pdf
A relative description on Sonoporation.pdfA relative description on Sonoporation.pdf
A relative description on Sonoporation.pdf
 
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
All-domain Anomaly Resolution Office U.S. Department of Defense (U) Case: “Eg...
 
Orientation, design and principles of polyhouse
Orientation, design and principles of polyhouseOrientation, design and principles of polyhouse
Orientation, design and principles of polyhouse
 
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxAnalytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
 

ENDOMYOCARDIAL FIBROSIS

  • 1. ENDOMYOCARDIAL FIBROSIS (Davies' disease) DR VISHWANATH HESARUR SENIOR RESIDENT DEPT OF CARDIOLOGY JNMC, BELGAUM.
  • 2. INTRODUCTION  Endomyocardial fibrosis (EMF) is a disease that is characterized by fibrosis of the apical endocardium of the right ventricle (RV), left ventricle (LV), or both.  The clinical manifestations are largely related to the consequences of restrictive ventricular filling, including left and right sided heart failure.  The heart failure is associated with atrioventricular-valve regurgitation.  Endomyocardial fibrosis is a major cause of illness and death in areas where it is endemic, and in its severest form carries a very poor prognosis, with an estimated survival of 2 years after diagnosis.
  • 3. HISTORY  1946: Bedford and Konstam described a form of heart disease in 40 West African soldiers -post-mortem revealed subendocardial fibrosis with features that are now associated with EMF.  1946: Davies JN first coined the term EMF and said that “he became convinced rightly or wrongly that he had met a new disease”.  1938 : Arthur Williams had described two cases of mitral incompetence and correlated with large patches of fibrosis affecting the ventricular walls at necropsy
  • 4.  1946 : Davies did his MD thesis on this disease where he described the pathological features as a distinct entity.  1948 : Bedford encouraged davies to publish his observations and Arthur Williams and JD Ball were his co-authors.  Later, JD Ball, with his missionary job joined Christian Medial College Vellore in India and identified the pathological specimens at autopsy which he shipped to Davies for confirmation. Thus, the disease was reported from India for the first time  1954 : Davies described the classical four pathological features of EMF and its distribution in Africa. Right and left ventricular endocardial fibrosis, affecting the apex and inflow region with atrioventricular valve regurgitations The disease came to be known as the Davies’ disease.
  • 5.  1960 : Samuel and Anklesaria published this initial autopsy series from south India.  1962 : CK Gopi from Trivandrum, described the specimen kept in the hospital autopsied in 1950s as a case of right ventricular endomyocardial fibrosis with right atrial thrombi.
  • 6. EPIDEMIOLOGY  EMF is a disorder found typically in tropical and subtropical Africa, notably in Uganda, Nigeria, and Mozambique  Major cause of morbidity and mortality, accounting for 25% of cases of congestive heart failure and death in equatorial Africa.  A population-based study in rural Mozambique revealed a prevalence of the disorder affecting 19.8% of the population.
  • 7.  The disease is increasingly recognized in other tropical and subtropical regions within 15 degrees of the equator, including India, Brazil, Colombia, and Sri Lanka.
  • 8.  Increased incidence among individuals of low socioeconomic status.  Male preponderance, is most common in children and young adults, but has been described in individuals into the sixth decade of life .
  • 9. ETIOLOGY  The cause of the underlying fibrotic process of EMF is largely unknown; however, several theories exist and are briefly reviewed Eosinophilia  Most commonly cited etiologic link in EMF.  In support - observed that EMF resembles a late stage of Loeffler's endocarditis (eosinophilic myocarditis) , a process known to result from sustained eosinophilia in patients with hypereosinophilic syndrome .  EMF and intraventricular thrombosis have also been observed following a variety of other eosinophilic syndromes including hypersensitivity myocarditis , parasitic infections , eosinophilic leukemia, sarcoma, carcinoma, and lymphoma .
  • 10.  Despite the similarities between Loeffler’s endocarditis and EMF, serum and myocardial eosinophilia have not been consistently demonstrated in EMF.  one study from Uganda found - 60 % of patients with EMF had at least mild eosinophilia at the time of diagnosis compared to 10 % of controls , in Kerala, India, most with EMF did not have active eosinophilia at the time of diagnosis.  Endomyocardial biopsies have not demonstrated eosinophilia in EMF, even in those suspected to have early disease .
  • 11. Infectious  Several infections - toxoplasmosis , rheumatic fever , malaria , and helminthic parasites .  A consistent association with one organism, however, has not been demonstrated. Environmental exposure  Cerium, a rare earth element, has been postulated to play a role in the pathogenesis of EMF.  Serum levels of cerium are high in patients with EMF compared to controls, and it is postulated that cerium is ingested from food and contaminated soil .  The incidence of EMF is decreasing in India, which corresponds with a reduction in soil cerium that has occurred with modernization.
  • 12. Immunologic  The presence of anti-myosin autoantibodies has been demonstrated in EMF; however, these antibodies can be detected in other forms of heart disease such as Dresser’s syndrome, rheumatic heart disease, and in patients with post-transplant rejection. Genetic  A familial link has been identified in many studies; however, it is not known whether this is due to an environmental or genetic cause or both.
  • 13. PATHOLOGY  EMF affects both the right and left ventricles in approximately 50% of patients, purely the left in 40%, and the right ventricle alone in the remaining 10%.  The typical gross appearance is that of a normal to slightly enlarged heart.  The right atrium may be dilated in proportion to the severity of right ventricular involvement.  The hallmark feature of the disorder is fibrotic obliteration of the apex of the affected ventricle .
  • 14.  The fibrosis involves the papillary muscles and chordae tendineae, leading to atrioventricular valve distortion and regurgitation.  In the left ventricle, the fibrosis extends from the apex to the posterior mitral valve leaflet, usually sparing the anterior mitral leaflet and the ventricular outflow tract.  Endocardial calcific deposits can be present involving diffuse areas of the ventricle.  The fibrotic tissue often creates a nidus for thrombus formation, which can be extensive. Atrial thrombi also occur.  The process usually does not involve the epicardium, and the coronary artery obstruction is distinctly uncommon.
  • 15. End-stage endomyocardial disease . Apical ventricular thrombi form in damaged endocardium, and progressive endomyocardial fibrosis entraps the chordae tendineae, leading to mitral and sometimes tricuspid valvular incompetence. (Courtesy Murray Resnick, MD, PhD, Brown University, Providence, RI.)
  • 16. HISTOLOGY Histology demonstrates marked fibrotic thickening of the endocardium (arrow), with proliferation of fibrous tissue in the underlying myocardium, which is consistent with endomyocardial fibrosis (Masson trichrome stain, original magnification Ă—50).
  • 17. CLINICAL FEATURES  The clinical presentation of EMF depends on the chamber involved, the location of the fibrotic lesion and its severity.  Davies described three phases of the disease in his patients from Uganda.  The initial phase is an acute carditis phase, characterized by febrile illness and in severe cases with heart failure and shock.  Those who survive this acute illness, progress into a sub acute phase followed by a chronic phase.  Most of the patients come to clinical attention in this chronic burnt-out phase
  • 18. Right Ventricular Endomyocardial Fibrosis  In pure or predominant right ventricular involvement, the right ventricular apex is characterized by fibrous obliteration, which may extend to involve the supporting structures of the tricuspid valve, with ensuing tricuspid regurgitation.  Patients exhibit an elevated JVP, a prominent v wave with rapid y descent, and a right-sided S3 gallop.  There is prominent hepatomegaly with a pulsatile liver, ascites, splenomegaly, and peripheral edema, but pulmonary congestion is typically absent because of the lack of left-sided involvement.
  • 19. Left Ventricular Endomyocardial Fibrosis  In cases of predominant left-sided disease, fibrosis involves the ventricular apex and often the chordae tendineae or the posterior mitral valve leaflet, producing mitral regurgitation.  The associated murmur may be late systolic, characteristic of a papillary muscle dysfunction murmur, or pansystolic.  Findings of pulmonary hypertension may be prominent, and an S3protodiastolic gallop is frequently present.
  • 20. Biventricular Endomyocardial Fibrosis  Biventricular EMF is more common then either isolated right- or left-sided disease.  The typical clinical presentation of EMF resembles right ventricular EMF; however, a murmur of mitral regurgitation is indicative of left-sided involvement.  Unless left ventricular involvement is extensive, severe pulmonary hypertension is absent and the right-sided findings are the predominant mode of presentation.  Approximately 15% of patients will experience systemic embolization, and only 2% will have infective endocarditis.
  • 21.
  • 22.  In a study conducted in india which included 145 pts with EMF show clinical profile  The mean (SD) age of the patients at first presentation was 26±3 (14±1) years for women (n = 70) and 21±1 (11±9) years for men (n = 75); 33.1% were under 15. Gupta PN, Valiathan MS, Balakrishnan KG, Kartha CC, Ghosh MK. Clinical course of endomyocardial fibrosis. Br Heart J. 1989;62:450–4. Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum 69501 1, Kerala, Indi
  • 23. A COMPARISON OF THE CLINICAL AND CARDIOLOGICAL FEATURES OF ENDOMYOCARDIAL DISEASE IN TEMPERATE AND TROPICAL REGIONS J. DAVIES ,G. VIJAYARAGHAVAN et al A comparison of the clinical and cardiological features of endomyocardial disease in temperate and tropical regions,1983.
  • 24. J. DAVIES ,G. VIJAYARAGHAVAN et al A comparison of the clinical and cardiological features of endomyocardial disease in temperate and tropical regions,1983.
  • 25. RV EMF  Right atrial (RA) abnormality - peaking and increased P wave amplitude in lead II Tharakan J. Electrocardiogram in endomyocardial fibrosis. Indian J Pacing Electrophysiol.2011;11:129–33 ECG DIAGNOSIS
  • 26.  QR pattern with a diminutive R wave in lead V1 , attributed to RA enlargement, though this pattern is seen even in patients with atrial fibrillation (AF) . Tharakan J. Electrocardiogram in endomyocardial fibrosis. Indian J Pacing Electrophysiol.2011;11:129–33
  • 27.  In isolated RV EMF - A dominant R wave in V2 in the absence of QR pattern in V1 in 14 of 25 patients resulting in early transition from a dominant S wave in right sided chest leads to dominant R wave in V2 or earlier . Tharakan J. Electrocardiogram in endomyocardial fibrosis. Indian J Pacing Electrophysiol.2011;11:129–33
  • 28.  AF is seen in the end stage patients with advanced RV EMF.  It is noteworthy that patients with RV EMF and AF rarely have fast ventricular response, in striking contrast to patients with AF and LV EMF.  Patients with large pericardial effusion often have low voltage QRS, satisfying the low voltage ECG criteria.
  • 29. LV EMF  LA abnormality.  AF occurs in advanced and uncorrected case of LVEMF.  The odd finding is a uniform ST segment depression and T wave inversion more evident in the lateral chest leads, similar to apical hypertrophic cardiomyopathy (HCM) and non- ST elevation acute coronary syndromes
  • 30. Tharakan J. Electrocardiogram in endomyocardial fibrosis. Indian J Pacing Electrophysiol.2011;11:129–33
  • 31.  More than 50% patients with EMF have biventricular involvement  The ECG reflects a combination of these abnormalities.  ECG findings reported by Balakrishnan et al from Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum - 210 patients  AF (33%), junctional rhythm or heart block (4.4%), right axis deviation (29%), intra ventricular conduction abnormality (16%) and atrial tachycardia or atrial flutter(3.5%). Balakrishnan KG, et al. Clinical course of patients in Kerala. In: Valiathan MS, editor.Endomyocardial fibrosis. Oxford University Press; 1993
  • 32.  Earlier three large studies of 60 patients, 95 patients and 50 patients, reported AF in 40%, junctional rhythm in 2%, RA enlargement in 32% and QR pattern in V1 in 25% patients .  LA enlargement was common in patients with LVEMF and 18% of LVEMF patients had LVH (left ventricular hypertrophy) with strain . Sapru RP. Clinical profile of endomyocardial fibrosis. In: Sapru RP, editor. Endomyocardial fibrosis in India. ICMR; 1983. Vijayaraghavan G, et al. Endomyocardial fibrosis: Clinical, ECG and radiological features. In: Sapru RP, editor. Endomyocardial fibrosis in India. ICMR; 1983. Jacob G, et al. Endomyocardial fibrosis in Kerala. In: Sapru RP, editor. Endomyocardial fibrosis in India. ICMR; 1983. Jacob G, et al. Endomyocardial fibrosis in Kerala. In: Sapru RP, editor. Endomyocardial fibrosis in India. ICMR; 1983
  • 33. Echocardiography  Apical fibrosis of the right ventricle (RV), left ventricle (LV), or both ventricles.  Tethering the atrioventricular (AV) valve papillary muscles, leading to mitral and/or tricuspid regurgitation  Giant atrial enlargement .  Restrictive filling pattern on Doppler recordings of mitral valve inflow .  Apical thrombi are often present
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.  In a study conducted in brazil - 12 pts with EMF were studied with Doppler echocardiography with the purpose of describing the echocardiographic features and identify the affected sites.  The average age was 41 years (range 16 to 59 years), 2 men and 10 women.  3 (25%) had isolated right ventricular involvement, one patient (8%) left ventricular, 8 patients (66%) both ventricular.  Doppler echocardiographic findings were: right atrium enlargement (91%), right ventricle outflow dilatation (83%), paradoxical septal motion (83%), left atrial enlargement (33%), mitral and tricuspid valve prolapse (50%), pericardial effusion (41%), mitral regurgitation (75%), tricuspid regurgitation (100%), apex obliteration (50%) and a restrictive type flow pattern (50%). Tello r Cuan et al . Doppler echocardiography in endomyocardial fibrosis , Brazil ,1994.
  • 40.  In a study conducted in india which included 145 pts with EMF ,Echocardiographic data were available in 86 patients.  The mean (SD) left ventricular internal dimensions in diastole and systole were 4.17 (1.19) cm and 2.9 (1. 07) cm respectively.  Pericardial effusion was present in 35 (40.7%), intracavitary thrombi in 11 (12.8%), and myocardial calcification in 16 (18. 6%) patients. Gupta PN, Valiathan MS, Balakrishnan KG, Kartha CC, Ghosh MK. Clinical course of endomyocardial fibrosis. Br Heart J. 1989;62:450–4. Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum 69501 1, Kerala, India
  • 41.  An echocardiographic screening study in Mozambique included echocardiographic criteria for the diagnosis and staging of EMF  As the natural history of EMF is not well defined, these criteria will likely aid in defining the stages of this disease and in determining the clinical significance of early EMF.
  • 42. Classification of Endomyocardial Fibrosis  They defined major and minor criteria for the diagnosis of EMF on the basis of features of advanced disease and pathologic features of early stages described in postmortem studies.  Endomyocardial fibrosis was diagnosed in the presence of two major criteria or one major criterion associated with two minor criteria  Possible scores ranged from 0 to 35; cases with ď‚— scores of 8 or less were classified as mild, ď‚— scores of 8 to 15 as moderate, ď‚— scores of 15 or more as severe.
  • 43. A Population Study of Endomyocardial Fibrosis in a Rural Area of Mozambique Ana Olga Mocumbi, M.D., Maria Beatriz Ferreira, M.D., Ph.D., Daniel Sidi, M.D., Ph.D., and Magdi H. Yacoub, F.R.S. N Engl J Med 2008;359:43-9.
  • 44. HEMODYNAMIC FINDINGS  The typical haemodynamic finding on cardiac catheterization is the dip and plateau pattern of restrictive ventricular filling.
  • 45.  In a study conducted in Mozambique included 21 pts showed  In patients with RV EMF, RA pressure was increased with prominent A waves, which was also seen in the right ventricular and pulmonary artery pressure tracings .  The right ventricular pressure tracing showed a dip and high end-diastolic pressure 5 mm Hg higher than the pulmonary diastolic pressure, and the contour of the right ventricular pressure tracing was distorted .
  • 46.  In patients with left sided involvement, left ventricular end- diastolic pressure was very high.  A dip and plateau pattern of the ventricular pressure curve present .  Pulmonary hypertension present in all patients with left and biventricular EMF
  • 47.
  • 48.
  • 49.
  • 50.  In a study conducted which included 8 pts, their hemodynamics showed Vijayaraghavan G, Cherian G, Krishnaswami S, Sukumar IP. Left ventricular endomyocardial fibrosis in India. Br Heart J. 1977;39:563–8
  • 51. Gupta PN, Valiathan MS, Balakrishnan KG, Kartha CC, Ghosh MK. Clinical course of endomyocardial fibrosis. Br Heart J. 1989;62:450–4. Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum 69501 1, Kerala, India
  • 52. Chest X-Ray  Cardiomegaly - varying degrees from mild to severe.  Right atrial enlargement in the patients with right-sided involvement, left atrial enlargement in patients with left- sided involvement, and biatrial enlargement in those with biventricular involvement.  Pulmonary venous congestion with left-sided involvement.  Endocardial calcification
  • 53.
  • 54. Somers K, Williams AW. Intracardiac calcification in endomyocardial fibrosis. Br Heart J.1962;24:324–8
  • 55. Vijayaraghavan G, Cherian G, Krishnaswami S, Sukumar IP. Left ventricular endomyocardial fibrosis in India. Br Heart J. 1977;39:563–8
  • 56.
  • 57.
  • 58. ANGIOGRAPHY CHARACTERISTIC OBLITERATION OF THE APEX OF THE INVOLVED VENTRICLE(S) WITH VARYING DEGREE OF AV VALVE REGURGITATION Left ventricular angiogram in the RAO view showing obliteration of the apex (arrow) in systole (top, a) and diastole (bottom, b). Walid M. Hassan, MD, FCCP; Mohamed et al Pitfalls in Diagnosis and Clinical, Echocardiographic, and Hemodynamic Findings in Endomyocardial Fibrosis A 25-Year Experience 2005
  • 59. Right ventricular angiogram in the RAO view in a patient with right-sided EMF showing complete obliteration of the apex of the right ventricle, dilated right atrium, and severe TR. . Walid M. Hassan, MD, FCCP; Mohamed et al Pitfalls in Diagnosis and Clinical, Echocardiographic, and Hemodynamic Findings in Endomyocardial Fibrosis A 25-Year Experience 2005
  • 60.
  • 61.  CMR imaging with contrast demonstrates myocardial fibrosis.  In early disease where there is suspicion for active inflammation, CMR may be useful in identifying patients who may benefit from steroid therapy Cardiovascular magnetic resonance imaging
  • 63. Endomyocardial Biopsy Photomicrograph of endomyocardial biopsy specimen showing marked thickening of the endocardium (E) with fibrosis (hematoxylin-eosin, original Ă— 200).
  • 64. MANAGEMENT Medical therapy  Remains challenging.  One third to one half of patients with advanced disease die within 2 years  Atrial fibrillation is a poor prognostic indicator, although symptomatic relief can be achieved with rate control  Heart failure - difficult to control, and diuretics are effective only in early stages of disease, losing efficacy with advanced ascites.
  • 65. Surgery  Endomyocardial resection - endocardectomy with valve replacement or repair - especially in subjects in advanced heart failure  Immediate postoperative mortality is high - 15 to 30 %.  A surgical series of 83 patients from Brazil all in NYHA class grade III to IV, and with a mean follow-up of 7.6 years had a survival probability at 17 years of 55 percent . ď‚— 4 (5.8%) patients - recurrence of the fibrosis and were reoperated on and in 6 (8.8%), EMF appeared in the other ventricle. ď‚— 5 (7.3%) patients were reoperated on to replace either a valve prosthesis or a native valve which had been preserved during the first procedure. ď‚— Only 24 (45%) of the 53 surviving patients are in functional class I or II. Fernando Moraes , Cleuza et al Surgery for endomyocardial fibrosis revisited September 1998
  • 66.  Published series have been small, overall experience is limited, and questions remain about the appropriate timing, peri-operative mortality, and long-term prognosis .
  • 67. Left ventricular angiogram in the RAO view showing a small left ventricle with apical obliteration,severe MR, and dilated left atrium in a patient with left-sided EMF (top, a) and after surgery with endocardectomy and mitral valve replacement (bottom, b). Fernando Moraes , Cleuza et al Surgery for endomyocardial fibrosis revisited September 1998
  • 68. CLINICAL COURSE  The factors significantly affecting survival were Gupta PN, Valiathan MS, Balakrishnan KG, Kartha CC, Ghosh MK. Clinical course of endomyocardial fibrosis. Br Heart J. 1989;62:450–4. Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum 69501 1, Kerala, India
  • 69. Gupta PN, Valiathan MS, Balakrishnan KG, Kartha CC, Ghosh MK. Clinical course of endomyocardial fibrosis. Br Heart J. 1989;62:450–4. Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum 69501 1, Kerala, India
  • 70. Changing natural history of endomyocardial fibrosis  Gupta and colleagues defined the natural history of the disease in Kerala in the late 1980s.  Follow up of the initial 200 patients showed a 10 year survival of only 37 %.  Ascites, atrial fibrillation and NYHA class IV were the poor prognostic indicators.
  • 71.  Eighty nine patients, who underwent endocardiectomy with MVR had an actuarial survival of 55 % during the same period.  Significant decline in the number of new cases happened in the hospital admissions in Kerala in the subsequent decades.  Natural history in them was more favourable with less than 10 per cent mortality on seven years follow up.  The average number of cases seen declined by half in the last decade, compared to the previous decade.
  • 72.  The mean age of the patients seen is now 33 yr compared to 25 yr in the previous decade, suggesting that people who were asymptomatic in the previous era are now being picked up on evaluation.  There are no patients below 10 yr, whereas in the previous decade, 28 per cent were below the age of 15 yr.  The patients are less symptomatic and older.  The majority are incidentally diagnosed when evaluated for electrocardiographic or echocardiographic abnormalities.
  • 73.  Temporal correlates of this changing natural history are worth analyzing.  The period noted in the natural history studies belong to the 30 year period of 1976 to 2007  Kerala witnessed substantial economic, nutritional and health transitions.  Cassava and plantain are no longer the staple diet for the Keralites.  The per capita calorie consumption increased from 1600 to 2100 Kcals.  The nutritional deficiency disorders were replaced by those of over nutrition and currently, Kerala is the diabetic capital for India.  Thanks to the good female literacy, health status of Kerala is acclaimed as an example for good health at low cost.
  • 74.  A community survey shows that there is a substantial decline in worm load per child.  Filarial endemicity continues to be little less, with rigorous governmental programmes initiated for its control.  Eosinophilia in children is now uncommon.  There is substantial decline in rheumatic fever and rheumatic heart disease in children of Kerala correlating with the improved health care services and quality of life.  The question which needs to be answered now is what really caused this decline; is it the change in living standards, or change in the dietary pattern or the reduction in childhood infections? By and large, endomyocardial fibrosis could be a reaction pattern of the endocardium to a variety of insults
  • 75.  Presence of interstitial fibrosis, myohypertrophy, and calcification speaks of the role of cytokines in its genesis.  Predominant right ventricular involvement in children could indicate an insult when the right ventricle could be more susceptible.  Right ventricle receives most of the umbilical venous return in utero and is more dominant.  But no antenatal cases are reported till date and the youngest report is that of a 4 month old baby.  The inflammatory response occurring in the younger age group could manifest as calcification in later years.  Whether this calcification has its similarity to vascular and valvar calcium occurring in older age group; if so, could it be the factor which holds the key for unraveling this mystery?
  • 76. SUMMARY  EMF is a restrictive cardiomyopathy observed in the tropics usually at the end-stage of the disease.  It may be indistinguishable from Loeffler’s endocarditis, observed in temperate climates.  The pathogenesis remains unknown; however, eosinophilia may play a role.  Echocardiography may show uni- or bilateral ventricular apex obliteration with severely dilated atria and a restrictive filling pattern.  The prognosis is poor, with a mortality estimated at 25 % per year.  Surgical treatment with endomyocardial resection and valve replacement may be beneficial in patients with advanced apical obliteration and sever heart failure symptoms.

Hinweis der Redaktion

  1. 1946: Bedford and Konstam described a form of heart disease in 40 West African soldiers . Several of these patients died 1946: Davies JN first coined the term endomyocardial fibrosis (EMF) while working in Uganda and said that “he became convinced rightly or wrongly that he had met a new disease”. He also discussed the initial clinical description of the disease by Bedford and Constam in 1946. 1938 : Arthur Williams, the foundation professor of medicine at Makerere University, Kampala, Uganda had described two cases of mitral incompetence and correlated with large patches of fibrosis affecting the ventricular walls at necropsy and this is perhaps the earliest documentation of EMF in literature
  2. Importantly, it is also recognized in the Middle East, particularly Saudi Arabia.[79] Cardiac dysfunction occurs because of fibrous lesions that affect the inflow of the right and left ventricles and that may also involve the atrioventricular valves, thereby producing regurgitant lesions.
  3. The cause of the underlying fibrotic process of EMF is largely unknown; however, several theories exist and are briefly reviewed In support of the eosinophilia theory is the observation that EMF resembles a late stage of Loeffler's endocarditis (eosinophilic myocarditis) (picture 1), a process known to result from sustained eosinophilia in patients with hypereosinophilic syndrome [12,13]. EMF and intraventricular thrombosis have also been observed following a variety of other eosinophilic syndromes including hypersensitivity myocarditis [14], parasitic infections [12,13], eosinophilic leukemia, sarcoma, carcinoma, and lymphoma [15], GM-CSF administration [16], and prolonged drug-induced eosinophilia
  4. Several infections have been implicated in the pathophysiology of EMF, including toxoplasmosis [20], rheumatic fever [21], malaria [22], and helminthic parasites [4,23]. A consistent association with one organism, however, has not been demonstrated. For example, mice infected with plasmodium berghei develop EMF lesions [24], but a study of a series of 47 African children aged 5 to 15 years old with severe and complicated plasmodium falciparum infection produced insufficient evidence to link these two diseases [25]. Also opposing the infectious hypothesis is the observation that there are many tropical countries with similar burdens of malaria and filariasis as Uganda and Nigeria that do not have reported cases of EMF
  5. There is often a pericardial effusion, which may be large. The right-sided heart border may be indented because of apical scarring.
  6. Presenting as a thick layer of collagen overlying loosely arranged connective tissue.[79] In addition, there are fibrous and granular septations extending into the underlying myocardial tissue. Myocyte hypertrophy is common.[52]  Whereas cellular infiltration is uncommon, interstitial edema is frequently present. Fibroelastosis that is found in the ventricular outflow tracts beneath the semilunar valves often represents a secondary process caused by local trauma. Examination of intramural coronary arteries may show involvement with medial degeneration, the deposition of fibrin, and fibrosis.
  7. The early part of the disease is rarely clinically recognized in India and the disease comes to attention in the late stages and isolated endocardial involvement and intracardiac thrombi are the peculiar features.
  8. In this regard, pulmonary artery and pulmonary capillary wedge pressures are normal. A large pericardial effusion is often present. The right atrium may be enormously dilated. The electrocardiogram often has findings consistent with right-sided enlargement, especially a qR pattern in lead V1, and supraventricular arrhythmias are common. The chest radiograph often demonstrates obvious right atrial prominence, a pericardial effusion, and calcification in the walls of the right and, less frequently, the left ventricle. Echocardiography demonstrates thickening of the right ventricle with obliteration of the apex, a dilated atrium, hyperechoic endocardial surfaces, and abnormal septal motion in patients with tricuspid regurgitation. On angiography, the right ventricular apex is typically not visualized because of fibrous obliteration; tricuspid regurgitation, right atrial enlargement, and filling defects in the right atrium caused by thrombi may be present.
  9. The electrocardiogram usually shows ST-segment and T wave abnormalities, low-voltage QRS complexes if a pericardial effusion is present, or left ventricular hypertrophy. Left atrial abnormality is often noted. As with right-sided involvement, atrial fibrillation is often present and portends a poor prognosis. Echocardiography reveals increased endocardial echoreflectivity, preserved systolic function, apical obliteration, enlarged atrium, pericardial effusion of varying size, and Doppler ultrasound evidence of mitral regurgitation. Pulmonary hypertension is typically observed during cardiac catheterization, as well as left atrial hypertension and a reduced cardiac index. Left ventriculography shows mitral regurgitation, and ventricular filling defects caused by intracavitary thrombi may be present. Coronary arteriography usually excludes obstructive epicardial vessel stenoses.
  10.  The ECG often suggests right atrial (RA) abnormality, reflecting RA pressure and volume overload . ECG abnormality includes peaking and increased P wave amplitude in lead II and rarely tall peaked and narrow positive P waves resembling the Himalayan P waves of Ebstein's anomaly.
  11.  Left atrial (LA) abnormality in ECG parallels the diastolic dysfunction and degree of mitral incompetence. AF occurs in advanced and uncorrected case of LVEMF. The odd finding is a uniform ST segment depression and T wave inversion more evident in the lateral chest leads, similar to apical hypertrophic cardiomyopathy (HCM) and non- ST elevation acute coronary syndromes
  12. Not uncommonly, nonspecific ST T wave abnormalities in the precordial leads in a routine ECG evaluation brings these patients to clinical attention for further evaluation to exclude coronary heart disease and LVEMF is diagnosed during echocardiographic study or LV angiogram.
  13. Although clinically similar to Loffler’s endocarditis, the diagnosis of endomyocardial fibrosis (EMF) should be reserved for patients from endemic regions without a clearly identified cause for sustained eosinophilia with the classic echocardiography features listed below : (image 3). In EMF, the apex maintains inward systolic contractile motion that may help to differentiate EMF from other causes of apical thrombi associated with an akinetic or dyskinetic apex such as myocardial infarction or Chagas disease [42] (figure 1).
  14. Doppler echocardiography is a useful method for the diagnosis of endomyocardial fibrosis, the finding of normal or small ventricles associated with apex obliteration and enlarged atria, mitral or tricuspid regurgitation and a restrictive type flow pattern are characteristics of this disease. In our population, the isolated or predominantely right ventricular involvement is the most common finding as it represented 83% of the cases.
  15. patients had markedly elevated ventricular filling pressures with characteristic restrictive hemodynamic pattern.
  16. Table 1 summarises the right and left heart catheterisation data.
  17. Calcification in endomyocardial fibrosis, as known in Uganda, has hitherto only been recognized at necropsy (Davies and Ball, 1955). In advanced cases of constrictive endocardial fibrosis, calcium deposition occurs in areas of extensive fibrosis particularly at the right ventricular apex.
  18. X-ray chest in an advanced case of right ventricular endomyocardial fibrosis often shows gross enlargement of the cardiac silhouette, predominantly contributed by the right atrial enlargement. But it can also be partly due to associated pericardial effusion as in this case. Varying degrees of pericardial effusion is a common association of severe right ventricular endomyocadial fibrosis with systemic venous congestion and anasarca.
  19. Features of pulmonary arterial hypertension in endomyocardial fibrosis (EMF) could be either due to left ventricular involvement and consequent elevation of left atrial and pulmonary venous pressures or due to pulmonary embolism from a right atrial thrombus as demonstrated earlier.
  20. Angiography characteristic obliteration of the apex of the involved ventricle(s) with varying degree of AV valve regurgitation in all patients with left ventricular or biventricular EMF (Fig 4). MR was severe in six patients (cases 2, 4, 16, 17, 18, and 21) [Fig 5] and mild to moderate in five patients (cases 1, 12, 13, 19, and 20). In patients with right ventricular involvement, there was obliteration of the right ventricular apex with dilation of the outflow tract. In one patient (case 7), there was exceptional involvement of the right ventricular inflow and outflow with obliteration of the apex (Fig 6). TR was severe in 5 patients and mild to moderate in 12 patients. Obliteration of both ventricular apices was observed in biventricular EMF. The contractility of the remaining parts of the ventricle varied from normal to severely impaired. Coronary angiographies were normal in all patients.
  21. Presently, cardiac MRI is a mainstay in the evaluation of the myocardium thickness and function, as well as the LV perfusion, allowing the assessment of the myocardial enhancement, which is a relevant factor in the diagnosis of several cardiac diseases.
  22. Nine specimens were obtained (done during our early experience with the disease), and seven specimens showed features of EMF, namely fibrous thickening of the endocardium, made up of collagen without elastic fibers (Fig 7). A few fibrocytes and an organized thrombus were seen in four specimens
  23. (See "Natural history and therapy of myocarditis in adults", section on 'Eosinophilic myocarditis'. . (See "Treatment and prognosis of diastolic heart failure" and "Definition and classification of the cardiomyopathies", section on 'Restrictive cardiomyopathy'.)
  24. The factors significantly affecting survival were considerable anaemia (haemoglobin < 100 g/l), development of embolic episodes, QRS axis more than + 90', delayed intraventricular conduction (QRS duration > 0 12 s), New York Heart Association classes III and IV, a short symptomatic history before admission to hospital, the presence of cyanosis, and left and/or right ventricular failure at first presentation (table 4). The analysis showed that age, sex, and predominantly right or left ventricular endomyocardial involvement had no effect on survival.